Quadcap Wealth Management LLC Has $1.68 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Quadcap Wealth Management LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,209 shares of the medical equipment provider’s stock after selling 34 shares during the period. Quadcap Wealth Management LLC’s holdings in Intuitive Surgical were worth $1,675,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Bennett Selby Investments LP increased its stake in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 17 shares during the period. Onefund LLC increased its stake in shares of Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after buying an additional 18 shares during the period. LVW Advisors LLC increased its stake in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after buying an additional 19 shares during the period. Wesbanco Bank Inc. increased its stake in shares of Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after buying an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC boosted its holdings in Intuitive Surgical by 1.9% in the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after acquiring an additional 19 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Trading Up 0.4%

Shares of Intuitive Surgical stock opened at $565.94 on Thursday. The firm has a market cap of $202.84 billion, a P/E ratio of 88.29, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12 month low of $386.00 and a 12 month high of $616.00. The stock’s fifty day moving average price is $502.26 and its 200-day moving average price is $535.79.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter last year, the firm posted $1.50 earnings per share. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 2,401 shares of the business’s stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the sale, the executive vice president now owns 353 shares in the company, valued at approximately $205,093. The trade was a 87.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 188 shares of the business’s stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the sale, the chief financial officer now owns 7,162 shares in the company, valued at $4,060,424.28. The trade was a 2.56% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 32,680 shares of company stock worth $16,854,345 over the last quarter. Insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the stock. Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Royal Bank of Canada dropped their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. UBS Group boosted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Truist Financial lowered their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a research report on Wednesday, April 23rd. Finally, Barclays reduced their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research report on Thursday, April 24th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.